// App-Quantinova.ai

OP0284 : AN AGENT-BASED SIMULATION OF THE EFFECTS OF VARYING TIME TO TREATMENT WITH BIOLOGICAL AGENTS ON PATIENT HEALTH AND COST IN AXIAL SPONDYLOARTHRITIS USING NATIONAL REGISTER DATA

Researchers

Presenter

  • A. Roach

Principal Investigators

  • I. Scott

  • G. Macfarlane

  • G. T. Jones

  • A. Macgregor

Medical Centers

  • The University of East Anglia, Norwich, United Kingdom

  • Keele University, Keele, United Kingdom

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Early inflammatory arthritis

  • Axial spondyloarthritis

  • Inflammatory Arthritis

  • Spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved